MYMDMyMD Pharmaceuticals, Inc.

Nasdaq mymd.com


$ 3.13 $ -0.27 (-8.11 %)    

Monday, 06-May-2024 15:36:41 EDT
QQQ $ 439.97 $ 4.77 (1.1 %)
DIA $ 388.40 $ 1.68 (0.43 %)
SPY $ 516.34 $ 5.28 (1.03 %)
TLT $ 90.16 $ 0.35 (0.39 %)
GLD $ 215.21 $ 2.24 (1.05 %)
$ 3.06
$ 3.13
$ 0.00 x 0
$ 3.33 x 200
$ 3.13 - $ 3.13
$ 2.00 - $ 70.50
25,515
na
4.72M
$ 2.04
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-12-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-18-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-25-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-20-2019 03-31-2019 10-Q
21 04-01-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 07-13-2018 03-31-2018 10-Q
25 04-03-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-15-2017 03-31-2017 10-Q
29 04-11-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-11-2016 06-30-2016 10-Q
32 05-12-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-13-2015 09-30-2015 10-Q
35 08-18-2015 06-30-2015 10-Q
36 05-14-2015 03-31-2015 10-Q
37 03-23-2015 12-31-2014 10-K
38 11-13-2014 09-30-2014 10-Q
39 08-12-2014 06-30-2014 10-Q
40 05-14-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

 mymd-pharmaceuticals-filing-from-late-monday-shows-co-entered-omnibus-waiver-and-amendment-agreement-with-required-holders-under-previously-announced-securities-purchase-agreement

As previously disclosed, on February 21, 2023, MyMD Pharmaceuticals, Inc. (the "Company") entered into a Securities Pur...

 why-biophytis-shares-are-trading-higher-by-around-55-here-are-20-stocks-moving-premarket

Shares of Biophytis S.A. (NASDAQ: BPTS) rose sharply in today’s pre-market trading after reporting FY23 results.

 mymd-pharmaceuticals-regains-compliance-with-nasdaq-minimum-bid-price-requirement-for-continued-listing

MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyMD" or "the Company"), a clinical stage biopharmaceutical company...

 mymd-pharmaceuticals-announces-1-for-30-reverse-stock-split-to-maintain-nasdaq-listing

Common Stock Will Begin Trading on Split-Adjusted Basis on February 15, 2024MyMD Pharmaceuticals, Inc.® (NASDAQ:MYMD) ("MyM...

 why-datchat-shares-are-trading-lower-by-around-33-here-are-20-stocks-moving-premarket

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offe...

 mymd-pharmaceuticals-has-been-granted-canadian-patent-number-3013634-titled-methods-of-increasing-hair-growth-and-improving-hair-appearance

https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3013634/summary.html 

 why-lumiradx-shares-are-trading-lower-by-20-here-are-20-stocks-moving-premarket

Shares of LumiraDx Limited (NASDAQ: LMDX) fell sharply in pre-market trading after the company agreed to sell its point-of-ca...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION